Revisor Wealth Management LLC Purchases 192 Shares of The Clorox Company $CLX

Revisor Wealth Management LLC lifted its position in shares of The Clorox Company (NYSE:CLX) by 7.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 2,881 shares of the company’s stock after buying an additional 192 shares during the quarter. Revisor Wealth Management LLC’s holdings in Clorox were worth $370,000 at the end of the most recent quarter.

A number of other institutional investors also recently added to or reduced their stakes in CLX. Vident Advisory LLC bought a new stake in Clorox during the fourth quarter valued at about $456,000. Vise Technologies Inc. acquired a new stake in Clorox in the fourth quarter worth about $250,000. Public Employees Retirement System of Ohio boosted its holdings in Clorox by 0.5% in the fourth quarter. Public Employees Retirement System of Ohio now owns 60,035 shares of the company’s stock worth $9,750,000 after acquiring an additional 269 shares in the last quarter. Mackenzie Financial Corp boosted its holdings in Clorox by 30.5% in the fourth quarter. Mackenzie Financial Corp now owns 13,464 shares of the company’s stock worth $2,187,000 after acquiring an additional 3,148 shares in the last quarter. Finally, American Trust acquired a new stake in Clorox in the fourth quarter worth about $293,000. Institutional investors own 78.53% of the company’s stock.

Insiders Place Their Bets

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the business’s stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. The trade was a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 0.57% of the company’s stock.

Clorox Stock Up 0.4%

Clorox stock opened at $120.43 on Wednesday. The stock has a market capitalization of $14.73 billion, a PE ratio of 18.47, a price-to-earnings-growth ratio of 0.96 and a beta of 0.52. The Clorox Company has a 12 month low of $116.53 and a 12 month high of $171.37. The business has a 50 day simple moving average of $123.82 and a 200-day simple moving average of $130.86. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 EPS for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The business’s revenue was up 4.5% compared to the same quarter last year. During the same period in the previous year, the business earned $1.82 earnings per share. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. Clorox’s payout ratio is 76.07%.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on the company. UBS Group lowered their price target on Clorox from $150.00 to $134.00 and set a “neutral” rating for the company in a report on Thursday, July 17th. Morgan Stanley lowered their price target on Clorox from $150.00 to $137.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Wells Fargo & Company lowered their price target on Clorox from $138.00 to $130.00 and set an “equal weight” rating for the company in a report on Friday, September 5th. Citigroup reissued a “neutral” rating and issued a $135.00 price target (down previously from $140.00) on shares of Clorox in a report on Tuesday, July 15th. Finally, Barclays reduced their price objective on Clorox from $129.00 to $119.00 and set an “underweight” rating for the company in a research note on Tuesday, July 15th. One investment analyst has rated the stock with a Buy rating, eight have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Reduce” and an average target price of $142.18.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.